Sarepta Therapeutics, Inc.
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:7187 tCO2e (2023)
Scope 1 Emissions:4789 tCO2e (2023)
Scope 2 Emissions:2400 tCO2e (2023)
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:2,963,440 gallons (2023)
Waste Generated:149 metric tons (2022), 135 metric tons (2023)
Carbon Intensity:Not disclosed
ESG Focus Areas
- Research and Development Innovation
- Product Safety and Quality
- Ethical Marketing Practices
- Environmental Impact
- Data Privacy and Security
- Employee Health and Safety
- Inclusion, Belonging, and Connection
- Corporate Governance and Compliance
Environmental Achievements
- Implemented nighttime and weekend setback programs for lighting and heating; undertook a companywide re-lamping initiative to replace bulbs with LEDs; implemented recycling programs; employed single-stream recycling at Andover, MA site; established a sustainability committee in Ohio labs.
- Overall waste diversion rate of 31% in 2022 and 19% in 2023.
Social Achievements
- Increased women's representation in the workforce to 57% and in leadership to 52% in 2023; increased representation of people of color in the workforce to 34% and in leadership to 26% in 2023; no statistical evidence of gender or racial pay disparities found in 2023 pay equity analysis.
- Launched SareptAssist and SareptAlly programs to support patients; awarded Duchenne scholarships; provided grants to patient advocacy organizations; implemented competency-based interviewing; launched First Year Connections program for new hires; offered robust leave benefits.
Governance Achievements
- ESG oversight granted to the Nominating and Corporate Governance Committee; cybersecurity oversight to the Audit Committee; human capital oversight to the Compensation Committee; implemented data security program using industry best practices; annual cybersecurity training for all employees.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Intense competition for qualified employees; managing environmental footprint as the business grows; ensuring equitable access to clinical trials and treatments for all patients.
Mitigation Strategies
- Offering a comprehensive total rewards package; implementing sustainable commuting initiatives; developing programs to support patient access; implementing competency-based interviewing; launching First Year Connections program; offering robust leave benefits; providing upfront stipends and concierge services for clinical trial participants.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Risk-based vendor selection processes; quality agreements outlining roles and responsibilities.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: SASB
Certifications: Null
Third-party Assurance: Externally assured with limited level of assurance
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Human Rights Campaign Corporate Equality Index (95%)